Literature DB >> 16943303

Involvement of drug-specific T cells in acute drug-induced interstitial nephritis.

Zoi Spanou1, Monika Keller, Markus Britschgi, Nikhil Yawalkar, Thomas Fehr, Jörg Neuweiler, Mathias Gugger, Markus Mohaupt, Werner J Pichler.   

Abstract

Drug-induced interstitial nephritis can be caused by a plethora of drugs and is characterized by a sudden impairment of renal function, mild proteinuria, and sterile pyuria. For investigation of the possible pathomechanism of this disease, drug-specific T cells were analyzed, their function was characterized, and these in vitro findings were correlated to histopathologic changes that were observed in kidney biopsy specimens. Peripheral blood mononuclear cells from three patients showed a proliferative response to only one of the administered drugs, namely flucloxacillin, penicillin G, and disulfiram, respectively. The in vitro analysis of the flucloxacillin-reactive cells showed an oligoclonal immune response with an outgrowth of T cells bearing the T cell receptor Vbeta9 and Vbeta21.3. Moreover, flucloxacillin-specific T cell clones could be generated from peripheral blood, they expressed CD4 and the alphabeta-T cell receptor, and showed a heterogeneous cytokine secretion pattern with no clear commitment to either a Th1- or Th2-type response. The immunohistochemistry of kidney biopsies of these patients revealed cell infiltrations that consisted mostly of T cells (CD4+ and/or CD8+). An augmented presence of IL-5, eosinophils, neutrophils, CD68+ cells, and IL-12 was observed. In agreement with negative cytotoxicity assays, no cytotoxicity-related molecules such as Fas and perforin were detected by immunohistochemistry. The data indicate that drug-specific T cells are activated locally and orchestrate a local inflammation via secretion of various cytokines, the type of which depends on the cytokine pattern secreted and which probably is responsible for the renal damage.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16943303     DOI: 10.1681/ASN.2006050418

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  25 in total

1.  Prophylactic use of gentamicin/flucloxacillin versus cefuroxime in surgery: a meta analysis of clinical studies.

Authors:  Shaoning Luo; Yu Lai; Chunxin Liu; Yi Chen; Xiaoyu Qiao
Journal:  Int J Clin Exp Med       Date:  2015-10-15

2.  Kidney injuries related to ipilimumab.

Authors:  Hassane Izzedine; Victor Gueutin; Chems Gharbi; Christine Mateus; Caroline Robert; Emilie Routier; Marina Thomas; Alain Baumelou; Philippe Rouvier
Journal:  Invest New Drugs       Date:  2014-04-01       Impact factor: 3.850

Review 3.  Pharmacology behind Common Drug Nephrotoxicities.

Authors:  Mark A Perazella
Journal:  Clin J Am Soc Nephrol       Date:  2018-04-05       Impact factor: 8.237

Review 4.  Delayed drug hypersensitivity: models of T-cell stimulation.

Authors:  Jacqueline Adam; Werner J Pichler; Daniel Yerly
Journal:  Br J Clin Pharmacol       Date:  2011-05       Impact factor: 4.335

Review 5.  Differentiating Acute Interstitial Nephritis from Acute Tubular Injury: A Challenge for Clinicians.

Authors:  Dennis G Moledina; Chirag R Parikh
Journal:  Nephron       Date:  2019-06-14       Impact factor: 2.847

Review 6.  Renal effects of targeted anticancer therapies.

Authors:  Camillo Porta; Laura Cosmai; Maurizio Gallieni; Paolo Pedrazzoli; Fabio Malberti
Journal:  Nat Rev Nephrol       Date:  2015-03-03       Impact factor: 28.314

7.  Urine TNF-α and IL-9 for clinical diagnosis of acute interstitial nephritis.

Authors:  Dennis G Moledina; F Perry Wilson; Jordan S Pober; Mark A Perazella; Nikhil Singh; Randy L Luciano; Wassim Obeid; Haiqun Lin; Michael Kuperman; Gilbert W Moeckel; Michael Kashgarian; Lloyd G Cantley; Chirag R Parikh
Journal:  JCI Insight       Date:  2019-05-16

Review 8.  Kidney Complications of Immune Checkpoint Inhibitors: A Review.

Authors:  Roman Shingarev; Ilya G Glezerman
Journal:  Am J Kidney Dis       Date:  2019-07-11       Impact factor: 8.860

9.  Non-steroidal anti-inflammatory drugs-associated acute interstitial nephritis with granular tubular basement membrane deposits.

Authors:  Mehul P Dixit; Cuong Nguyen; Thomas Carson; Ben Guedes; Naznin M Dixit; Jane M Bell; Yihan Wang
Journal:  Pediatr Nephrol       Date:  2007-09-19       Impact factor: 3.714

10.  Acute tubulointerstitial nephritis associated with atezolizumab, an anti-programmed death-ligand 1 (pd-l1) antibody therapy.

Authors:  M Xipell; I Victoria; V Hoffmann; J Villarreal; A García-Herrera; O Reig; L Rodas; M Blasco; E Poch; B Mellado; L F Quintana
Journal:  Oncoimmunology       Date:  2018-03-26       Impact factor: 8.110

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.